USPTO serial 79436458
ONEMAP
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 29, 2026
- Examiner
- ROACH, APRIL K
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ONEMAP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Pamela N. Hirschman
Pamela N. Hirschman Davis Graham & Stubbs LLP3400 Walnut Street, Suite 700Denver, CO 80205United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software and downloadable software application for biological, chemical and medical analysis; downloadable software and downloadable software applications for medical diagnosis; downloadable electronic databases in the fields of biology, chemistry and medicine | ACTIVE | — |
| 035 | Database management; collection of data, namely, medical, chemistry and biological data, for business purposes; data systematization in computer databases; provision of data, namely, providing a database featuring consumer product information in the field of medical diagnostic products; compilation of information in computer databases; services for gathering data in computer databases, namely, compilation of information into computer databases; systematization of information in computer databases; data processing services; updating of data and metadata in computer databases; subscriptions to database services, namely, arranging of subscriptions to databases for others, by telecommunications; all the aforesaid services in the fields of biological and chemical analyses, medical diagnostics and clinical trials | ACTIVE | — |
| 042 | Design, development, installation, updating, maintenance of software; Software as a Service (SaaS) featuring software for biological, chemical and medical analysis; design and development of databases; conducting of scientific and technical studies, namely, conducting scientific feasibility studies and feasibility studies in the fields of biology, chemistry and medicine; scientific and technological research and design services, and scientific analysis, in the field of medical diagnostics; development and testing of methods and algorithms in the field of medical diagnostics; electronic data storage; hosting of databases; all the aforesaid services being in the fields of biological and chemical analyses, medical diagnostics and clinical trials | ACTIVE | — |
| 044 | Single-cell medical testing and analysis services for cancer prognosis, diagnosis and treatment as well as for diagnosis or treatment of other diseases; medical services; diagnostic services, namely, medical diagnostic testing for cancer as well as for other diseases and disorders; medical tests, namely, medical testing services, for diagnostic or treatment purposes; medical testing for the diagnosis and treatment of persons; laboratory analysis services, namely, medical laboratory analysis, blood analysis services provided by medical laboratories, relating to the treatment of persons; medical services in the field of oncology and other medical fields; provision of medical information in the field of health; providing screening services for cancer and other diseases, namely, providing medical diagnostic testing services consisting essentially of chemical analysis and use of bioinformatics tools for cancer screening; provision of medical information collected and analyzed for the purpose of diagnosis or treatment of cancer and other diseases and disorders; provision of medical data, namely, data about cancer treatment options and medical information intended for healthcare professionals. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ONE BIOSCIENCES
- Other trademarks owned by ONE BIOSCIENCES
- Other trademarks owned by ONE BIOSCIENCES
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ONEMAP
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 29, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 29, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 11, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 11, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 5, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 15, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 15, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 15, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 15, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 15, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 15, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 15, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 15, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 2, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 2, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 2, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 5, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 18, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 18, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 23, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 22, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 21, 2026 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Dec 18, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 17, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 16, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 8, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 8, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 6, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |